Correction: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection

Authors

Saboor Hekmati
Rodrígo Mora (ORCID: https://orcid.org/0000-0001-7964-3575)
Timothy J. Triche (ORCID: https://orcid.org/0000-0003-4869-8826)
Ram Yogendra (ORCID: https://orcid.org/0000-0001-7966-4093)
Xaiolan Chang
Dennis T. Maglinte (ORCID: https://orcid.org/0000-0001-8903-0836)
Bruce K. Patterson (ORCID: https://orcid.org/0000-0001-9793-9986)
Emily Long (ORCID: https://orcid.org/0000-0003-1512-4471)
Edgar B. Francisco
Javier Mora (ORCID: https://orcid.org/0000-0002-9288-1858)
Amruta Pise
Hallison Rodrigues
Purvi Parikh
Monica Herrera
Jose Guevara-Coto
Eric Hall
Paul Scott

Institutions

Oregon National Primate Research Center (US)
Bio-Rad (United States) (US)
Universidad de Costa Rica (CR)
NYU Langone Health (US)
RF Laboratories (United States) (US)
Incell Corporation (United States) (US)
Hospital for Tropical Diseases (VN)
Lawrence General Hospital (US)

Publication Details

Journal: Frontiers in Immunology
Published: 2026-04-23
DOI: https://doi.org/10.3389/fimmu.2026.1832958
Primary Topic: Long-Term Effects of COVID-19
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Correction: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection

Saboor Hekmati, Rodrígo Mora, Timothy J. Triche, Ram Yogendra et al.

Apr 23, 2026

Frontiers in Immunology

Long-Term Effects of COVID-19

article

Correction: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection

Saboor Hekmati, Rodrígo Mora, Timothy J. Triche, Ram Yogendra, Xaiolan Chang, Dennis T. Maglinte, Bruce K. Patterson, Emily Long, Edgar B. Francisco, Javier Mora, Amruta Pise, Hallison Rodrigues, Purvi Parikh, Monica Herrera, Jose Guevara-Coto, Eric Hall, Paul Scott

April 23, 2026article en

Abstract

No abstract available for this paper.

Frontiers in ImmunologyVol. 17

Oregon National Primate Research Center (US), Bio-Rad (United States) (US), Universidad de Costa Rica (CR), NYU Langone Health (US), RF Laboratories (United States) (US), Incell Corporation (United States) (US), Hospital for Tropical Diseases (VN), Lawrence General Hospital (US)

Openalex Percentile: Top 19%

Long-Term Effects of COVID-19

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection — Saboor Hekmati, Rodrígo Mora, et al. · Frontiers in Immunology (2026) | TGRS Research Map | TGRS